An Improved Benefit-Risk Profile of Duvelisib in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received >= 2 Prior Therapies

Matthew Davids, Peter Hillmen, Marco Montillo, Julio Delgado, Bryone Kuss, Constantine Tam, Ulrich Jaeger, Paolo Ghia, Stephan Stilgenbauer, Florence Cymbalista, Stephanie Lustgarten, David Weaver, Hagop Youssoufian, Ian Flinn